Invivyd Expanded Headquarters Space in New Haven
The pharmaceutical company signed a lease for 33,000 square feet of office space at 205 Church St.
Updated on Sept. 28, 2026 in Commercial
Live Poll
Do you believe the expansion of local corporate headquarters benefits your community?
Invivyd has signed a new lease for 33,000 square feet of office space at 205 Church St. in New Haven. This move effectively triples the company's total headquarters office footprint from its previous location.
Why it matters
The company requires significantly more space to support its ongoing efforts to advance its infectious disease research programs. This expansion provides a larger base for operations as the firm continues its development work.
The new 33,000-square-foot lease at 205 Church St. comprises 17,322 square feet on the ground floor, 12,563 square feet on the mezzanine, and 2,750 square feet in the basement.
The players
Invivyd
This pharmaceutical company specializes in the development of antibody-based therapies for infectious diseases.
Marc Elia
He is the chief executive officer of Invivyd and took on the leadership role in August 2026.
Cooper Church LLC
This entity owns the commercial property located at 205 Church St. in New Haven.
Savills
This global real estate services firm acted as the representative for Invivyd during its office lease negotiations.
CBRE
This commercial real estate services company represented the landlord, Cooper Church LLC, during the transaction.
The details
Invivyd, which also maintains a research and development lab in Waltham, Massachusetts, secured the space through negotiations involving Savills and CBRE. The firm is currently known for producing the COVID-19 prevention drug Pemgarda and testing the drug candidate VYD2311.
Timeline
August 30, 2026: Marc Elia became CEO of Invivyd.
September 2026: Invivyd signed the new headquarters lease.
Roadmap
This move reflects a broader trend of pharmaceutical companies consolidating their office and research footprints to optimize collaborative workflows. By significantly increasing its New Haven footprint, Invivyd positions itself within a competitive cluster of life sciences organizations.
The expansion brings increased commercial activity to the downtown New Haven district near Church Street. Residents may notice heightened foot traffic as the company transitions into its larger headquarters space.
The takeaway
Companies expanding their physical office footprints often signal confidence in their long-term clinical trial pipelines. Readers should watch for future announcements regarding hiring or clinical progress as the facility becomes operational.
Further reading
For more information on the evolving office landscape in the area, visit Commercial.
Source note: This article includes information reported by Hartford Business Journal.
Live Poll
Do you believe the expansion of local corporate headquarters benefits your community?
